Disorders Causing Seizures Codexery

Huntington's disease

Fatal inherited neurodegenerative disorder with motor, cognitive, and psychiatric symptoms.

Huntington's disease

Huntington's disease (HD), also known as Huntington's chorea, is a fatal neurodegenerative disease that is usually inherited. It typically presents as a triad of progressive psychiatric, cognitive, and motor symptoms, with chorea—uncoordinated, involuntary 'dance-like' movements—being a hallmark. The disease is caused by a mutation in the huntingtin gene (HTT) involving an expansion of CAG repeats, leading to gradual damage to the basal ganglia region of the brain.

Quick Facts

Field
Neurology, Medical Genetics
Symptoms
Problems with motor skills including coordination and gait, mood, and mental abilities
Complications
Pneumonia, heart disease, physical injury from falls, suicide
Onset
3050 years old
Duration
Long term
Causes
Genetic (inherited or new mutation)
Diagnosis
Genetic testing
Differential
Sydenham's chorea, benign hereditary chorea, lupus, paraneoplastic syndrome, Wilson's disease
Treatment
Supportive care
Medication
Tetrabenazine
Prognosis
Invariably fatal, 1520 years from onset of symptoms
Frequency
415 in 100,000 (European descent)

Facts from the source article.

Lore & Background

The earliest known description of Huntington's disease was in 1841 by American physician Charles Oscar Waters, with further detail provided in 1872 by American physician George Huntington. The genetic basis was discovered in 1993 by an international collaborative effort led by the Hereditary Disease Foundation. Research and support organizations began forming in the late 1960s to increase public awareness, provide support, and promote research.

Reader's Guide

Huntington's disease is significant as a model for understanding trinucleotide repeat disorders and autosomal dominant neurodegenerative diseases. Its discovery and characterization have advanced genetic testing and raised ethical debates about testing minors, confidentiality, and disclosure. The disease affects about 4 to 15 in 100,000 people of European descent, with equal incidence in males and females. No cure exists; treatments such as tetrabenazine can relieve some movement symptoms. Complications like pneumonia, heart disease, and falls reduce life expectancy, with suicide accounting for about 9% of deaths. Research directions include determining the exact mechanism, improving animal models, testing medications, and studying stem-cell therapy to replace damaged neurons.

Did You Know?

More in Disorders causing seizures 1-24

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →